Showing results (61-70 of 134) with videos related to
Sort By:
Pageof 14
Investigational New Drugs|August 11, 2010
Phase I study of gemcitabine, docetaxel and imatinib in refractory and relapsed solid tumorsBiren Saraiya, Rashmi Chugh, Vassiliki Karantza, et al.Head & Neck|November 19, 2016
Free thyroid transfer: Short-term results of a novel procedure to prevent post-radiation hypothyroidismJeffrey Harris, Brittany Barber, Hani Almarzouki, et al.Health & Justice|December 23, 2014
A cluster randomized trial of utilizing a local change team approach to improve the delivery of HIV services in correctional settings: study protocolSteven Belenko, Christy Visher, Michael Copenhaver, et al.International Journal of Radiation Oncology, Biology, Physics|August 12, 2016
Free Thyroid Transfer: A Novel Procedure to Prevent Radiation-induced HypothyroidismJeffrey Harris, Hani Almarzouki, Brittany Barber, et al.Cancer|July 23, 2003
High-dose ifosfamide with mesna and granulocyte-colony-stimulating factor (recombinant human G-CSF) in patients with unresectable malignant mesotheliomaSusan M Talbot, Cathryn Rankin, Robert N Taub, et al.Cancer|January 22, 2013
Adjuvant therapy for high-grade, uterus-limited leiomyosarcoma: results of a phase 2 trial (SARC 005)Martee L Hensley, J Kyle Wathen, Robert G Maki, et al.Infection and Drug Resistance|March 24, 2017
Antibiotic resistance among Helicobacter pylori clinical isolates in Lima, PeruKevin F Boehnke, Manuel Valdivieso, Alejandro Bussalleu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2005
Phase II study of 9-nitro-camptothecin in patients with advanced chordoma or soft tissue sarcomaRashmi Chugh, Rodney Dunn, Mark M Zalupski, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2003
Crossover randomized comparison of intravenous versus intravenous/oral mesna in soft tissue sarcoma treated with high-dose ifosfamideJoseph R Mace, Mary L Keohan, Heinz Bernardy, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 2008
Randomized, phase II study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 in patients with advanced soft tissue sarcomaLaurence H Baker, Eric K Rowinsky, David Mendelson, et al.Pageof 14